Fred Alger Management, LLC Rocket Pharmaceuticals, Inc. Transaction History

Fred Alger Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $492,427 - $590,388	-12,495 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $7,974 - $12,127	-184 Reduced 1.45%	12,495 $554,000
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $295,420 - $755,288	12,679 New	12,679 $695,000
Q3 2020 Nov 13, 2020	SELL	$20.5 - $28.59 $451,000 - $628,980	-22,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $38,840 - $100,440	-4,000 Reduced 15.38%	22,000 $307,000
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $287,820 - $629,980	26,000 New	26,000 $592,000

243

106M

268K

119K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $792M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.